The latest thoracic oncology news
US cancer mortality continues rapid decline, driven by progress against lung cancer
The US cancer death rate declined by 29% from 1991 to 2017, including a 2.2%…
Browsing: Lung Cancer
Standard of care chemoradiation for stage III NSCLC is superior to two tested alternatives
Lung cancer is the leading cause of cancer death in the United States and approximately…
PET/CT plays role in lung adenocarcinoma management
According to an article published in the American Journal of Roentgenology (AJR), fluorodeoxyglucose PET (FDG PET) can…
Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases
Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print…
High BMI may improve cancer survival
Above average or high BMI – often linked to cancers, diabetes, cardiovascular and other diseases…
Common asbestos lung disease does not increase risk of lung cancer
People who are diagnosed with the most common form of asbestos-related lung disease are not…
Inadequacies in current early-stage lung cancer treatment revealed
Findings conducted by researchers from Tohoku University and Tohoku University Hospital have revealed why some existing…
Newly developed nanoparticles help fight lung cancer in animal model
Scientists have reported a new approach to treating lung cancer with inhaled nanoparticles developed at…
Protected: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing
This content is password-protected. To view it, please enter the password below. Password:
Getting cancer drugs to the brain is difficult, but a new ‘road map’ might make it easier
The human brain has some remarkable capabilities – including the ability to block cancer drugs…